SCHEMBL20042854

SCHEMBL20042854

Cc1cc(Cl)cc(C(=O)N2Cc3nc(C)nc(N4CCC4)c3C2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.42
HPGD P15428 2/20 0.39
P2RX7 Q99572 4/20 0.38
TP53 P04637 2/20 0.35
THRB P10828 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
GBA1 P04062 1/20 0.35
HSD17B10 Q99714 2/20 0.34
KDM4E B2RXH2 2/20 0.34
PROKR1 Q8TCW9 1/20 0.34
TSHR P16473 1/20 0.34
CASP1 P29466 1/20 0.34
CASP7 P55210 1/20 0.34
HSP90AA1 P07900 1/20 0.33
FABP3 P05413 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
FABP4 P15090 1/20 0.33
FABP5 Q01469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20042689 0.94 P2RX7 (0.39) GRM5P2RX7TP53THRBTDP1
SCHEMBL20042863 0.89 GRM5 (0.42) GRM5P2RX7TP53THRBTDP1
SCHEMBL20042656 0.87 KDM4E (0.37) GRM5HPGDP2RX7TP53THRB
SCHEMBL20042702 0.87 P2RX7 (0.49) P2RX7HSD17B10TSHRCYP3A4CYP2D6
SCHEMBL20042674 0.86 P2RX7 (0.37) P2RX7TP53THRBTDP1GBA1
SCHEMBL20042771 0.86 P2RX7 (0.47) GRM5HPGDP2RX7KDM4ETSHR
SCHEMBL20042751 0.85 HSD17B10 (0.49) HPGDP2RX7GBA1HSD17B10KDM4E
SCHEMBL20042743 0.85 P2RX7 (0.40) HPGDP2RX7GBA1HSD17B10KDM4E
SCHEMBL20042861 0.84 P2RX7 (0.39) GRM5HPGDP2RX7HSD17B10KDM4E
SCHEMBL20043028 0.84 KDM4E (0.40) GRM5HPGDP2RX7TP53TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018066718-A1 THERAPEUTIC COMPOUNDS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2018-04-12 WO disclosed